$DVA
DAVITA INC. Stock $dva

$dva Overview Financials Valuation SEC Filings Company Website

2010 Q4 Form 8-K Financial Statement

#000119312512296374 Filed on July 06, 2012

Income Statement

Concept	2010 Q4	2010 Q3	2010 Q2
Revenue	$1.647B	$1.650B	$1.582B
YoY Change	5.02%	4.81%	4.16%
Cost Of Revenue	$1.133B	$1.145B	$1.107B
YoY Change	3.47%	4.43%	5.22%
Gross Profit	$513.9M	$505.1M	$475.3M
YoY Change	8.6%	5.65%	1.73%
Gross Profit Margin	31.2%	30.62%	30.04%
Selling, General & Admin	$200.8M	$191.8M	$178.2M
YoY Change	12.18%	8.36%	2.77%
% of Gross Profit	39.07%	37.97%	37.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$60.10M	$58.50M	$58.30M
YoY Change	5.62%	2.99%	0.17%
% of Gross Profit	11.69%	11.58%	12.27%
Operating Expenses	$260.6M	$250.1M	$236.3M
YoY Change	10.47%	7.02%	2.03%
Operating Profit	$255.3M	$256.7M	$242.5M
YoY Change	7.57%	5.05%	2.93%
Interest Expense	-$51.90M	-$37.70M	-$40.90M
YoY Change	19.59%	-15.85%	-12.42%
% of Operating Profit	-20.33%	-14.68%	-16.87%
Other Income/Expense, Net	$1.100M	$800.0K	$700.0K
YoY Change	57.14%	-20.0%	-46.15%
Pretax Income	$132.2M	$218.0M	$195.5M
YoY Change	-32.06%	8.74%	2.82%
Income Tax	$39.90M	$75.00M	$71.20M
% Of Pretax Income	30.18%	34.4%	36.43%
Net Earnings	$69.02M	$119.4M	$107.9M
YoY Change	-37.08%	7.65%	1.94%
Net Earnings / Revenue	4.19%	7.24%	6.82%
Basic Earnings Per Share	$0.71	$1.16	$1.05
Diluted Earnings Per Share	$0.70	$1.15	$1.04
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2010 Q4	2010 Q3	2010 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$883.0M	$558.0M	$598.0M
YoY Change	56.01%	-7.31%	6.22%
Cash & Equivalents	$860.1M	$535.0M	$575.0M
Short-Term Investments	$23.00M	$23.00M	$23.00M
Other Short-Term Assets	$43.99M	$259.0M	$296.0M
YoY Change	-85.19%	0.0%	18.4%
Inventory	$76.01M	$69.00M	$69.00M
Prepaid Expenses
Receivables	$1.049B	$1.083B	$1.071B
Other Receivables	$345.0M	$293.0M	$231.0M
Total Short-Term Assets	$2.623B	$2.262B	$2.265B
YoY Change	13.89%	-2.04%	1.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.171B	$1.122B	$1.106B
YoY Change	5.96%	3.13%	2.88%
Goodwill	$4.091B
YoY Change	3.55%
Intangibles	$162.6M
YoY Change
Long-Term Investments	$35.00M	$34.00M	$33.00M
YoY Change	16.67%	6.25%	6.45%
Other Assets	$32.05M	$32.00M	$33.00M
YoY Change	-2.87%	-5.88%	-25.0%
Total Long-Term Assets	$5.492B	$5.365B	$5.313B
YoY Change	4.5%	2.6%	2.02%
TOTAL ASSETS
Total Short-Term Assets	$2.623B	$2.262B	$2.265B
Total Long-Term Assets	$5.492B	$5.365B	$5.313B
Total Assets	$8.114B	$7.627B	$7.578B
YoY Change	7.36%	1.18%	1.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$181.0M	$321.0M	$238.0M
YoY Change	2.28%	24.9%	3.03%
Accrued Expenses	$325.0M	$357.0M	$349.0M
YoY Change	13.64%	13.33%	5.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$74.89M	$96.00M	$97.00M
YoY Change	-25.11%	-4.95%	5.43%
Total Short-Term Liabilities	$924.3M	$1.112B	$1.119B
YoY Change	-11.71%	-0.18%	0.9%
LONG-TERM LIABILITIES
Long-Term Debt	$4.234B	$3.266B	$3.288B
YoY Change	19.87%	-8.16%	-8.13%
Other Long-Term Liabilities	$89.29M	$117.0M	$118.0M
YoY Change	-24.33%	-12.03%	-11.94%
Total Long-Term Liabilities	$4.323B	$3.383B	$3.406B
YoY Change	18.44%	-8.29%	-8.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$924.3M	$1.112B	$1.119B
Total Long-Term Liabilities	$4.323B	$3.383B	$3.406B
Total Liabilities	$5.694B	$5.306B	$5.276B
YoY Change	5.0%	-2.84%	-3.03%
SHAREHOLDERS EQUITY
Retained Earnings	$2.718B
YoY Change
Common Stock	$135.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.361B
YoY Change
Treasury Stock Shares	38.86M shares
Shareholders Equity	$1.978B	$2.321B	$2.301B
YoY Change
Total Liabilities & Shareholders Equity	$8.114B	$7.627B	$7.578B
YoY Change	7.36%	1.18%	1.84%

Cashflow Statement

Concept	2010 Q4	2010 Q3	2010 Q2
OPERATING ACTIVITIES
Net Income	$69.02M	$119.4M	$107.9M
YoY Change	-37.08%	7.65%	1.94%
Depreciation, Depletion And Amortization	$60.10M	$58.50M	$58.30M
YoY Change	5.62%	2.99%	0.17%
Cash From Operating Activities	$120.6M	$161.3M	$296.0M
YoY Change	-20.97%	-3.7%	39.36%
INVESTING ACTIVITIES
Capital Expenditures	-$104.2M	-$70.00M	-$56.80M
YoY Change	51.23%	3.7%	-12.62%
Acquisitions
YoY Change
Other Investing Activities	-$47.10M	-$45.40M	-$89.50M
YoY Change	65.85%	117.22%	-2812.12%
Cash From Investing Activities	-$151.3M	-$115.5M	-$146.2M
YoY Change	55.34%	30.8%	136.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	356.3M	-86.00M	-330.9M
YoY Change	-465.44%	106.73%	2612.3%
NET CHANGE
Cash From Operating Activities	120.6M	161.3M	296.0M
Cash From Investing Activities	-151.3M	-115.5M	-146.2M
Cash From Financing Activities	356.3M	-86.00M	-330.9M
Net Change In Cash	325.6M	-40.20M	-181.1M
YoY Change	-869.74%	-206.91%	-230.76%
FREE CASH FLOW
Cash From Operating Activities	$120.6M	$161.3M	$296.0M
Capital Expenditures	-$104.2M	-$70.00M	-$56.80M
Free Cash Flow	$224.8M	$231.3M	$352.8M
YoY Change	1.49%	-1.57%	27.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2010Q4	dva	Stock Repurchase Program Additional Authorized Repurchase Amount StockRepurchaseProgramAdditionalAuthorizedRepurchaseAmount	800000000
CY2010Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	3000000000
CY2010Q4	dva	Line Of Credit Facility Potential Maximum Borrowing Capacity LineOfCreditFacilityPotentialMaximumBorrowingCapacity	4000000000
CY2011Q3	dva	Number Of Centers Sold NumberOfCentersSold	28	Entity
CY2011Q4	dva	Number Of Centers Sold NumberOfCentersSold	2	Entity
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	410881000
CY2009Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Liabilities Incurred BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurred	338000
CY2009Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5548000
CY2009Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Cash Paid BusinessAcquisitionCostOfAcquiredEntityCashPaid	87617000
CY2009Q4	us-gaap	Goodwill Goodwill	3951196000
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	539459000
CY2009Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Purchase Price BusinessAcquisitionCostOfAcquiredEntityPurchasePrice	87955000
CY2009Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	30693000
CY2009Q4	dva	Business Acquisition Number Of Entities Acquired BusinessAcquisitionNumberOfEntitiesAcquired	19	Entity
CY2010Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32054000
CY2010Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Liabilities Incurred BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurred	449000
CY2010Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	18537000
CY2010Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10998000
CY2010Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	38721000
CY2010Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27438000
CY2010Q4	us-gaap	Available For Sale Securities Gross Unrealized Gain Loss AvailableForSaleSecuritiesGrossUnrealizedGainLoss	824000
CY2010Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	8381000
CY2010Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4317123000
CY2010Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	226060000
CY2010Q4	us-gaap	Assets Current AssetsCurrent	2622854000
CY2010Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	421436000
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	503000
CY2010Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1360579000
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	924345000
CY2010Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	33937000
CY2010Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	4072000
CY2010Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	65950000
CY2010Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	66820000
CY2010Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-195376000
CY2010Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4233850000
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2717817000
CY2010Q4	us-gaap	Interest Payable Current InterestPayableCurrent	22905000
CY2010Q4	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	216655000
CY2010Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1048976000
CY2010Q4	us-gaap	Assets Assets	8114424000
CY2010Q4	us-gaap	Derivative Higher Fixed Interest Rate Range DerivativeHigherFixedInterestRateRange	0.0470	pure
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	135000
CY2010Q4	us-gaap	Inventory Net InventoryNet	76008000
CY2010Q4	us-gaap	Minority Interest MinorityInterest	58712000
CY2010Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Cash Paid BusinessAcquisitionCostOfAcquiredEntityCashPaid	188502000
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2010Q4	us-gaap	Finite Lived Noncompete Agreements Gross FiniteLivedNoncompeteAgreementsGross	309405000
CY2010Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	342943000
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	96001535	shares
CY2010Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1107778000
CY2010Q4	us-gaap	Senior Notes SeniorNotes	1550000000
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2010Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	127073000
CY2010Q4	us-gaap	Goodwill Goodwill	4091307000
CY2010Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	216641000
CY2010Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3177000
CY2010Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	89290000
CY2010Q4	us-gaap	Land Land	23182000
CY2010Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	307622000
CY2010Q4	us-gaap	Derivative Lower Fixed Interest Rate Range DerivativeLowerFixedInterestRateRange	0.0405	pure
CY2010Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11272000
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	860117000
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2010Q4	us-gaap	Other Receivables OtherReceivables	304366000
CY2010Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	620546000
CY2010Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	61405000
CY2010Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	235629000
CY2010Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2310553000
CY2010Q4	us-gaap	Long Term Investments LongTermInvestments	8848000
CY2010Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	296624000
CY2010Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1139745000
CY2010Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	110472000
CY2010Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Purchase Price BusinessAcquisitionCostOfAcquiredEntityPurchasePrice	188951000
CY2010Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	49096000
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8114424000
CY2010Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	8466000
CY2010Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2010Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2010Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	7579000
CY2010Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	377456000
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	1978422000
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	134862283	shares
CY2010Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	379276000
CY2010Q4	us-gaap	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	383052000
CY2010Q4	us-gaap	Short Term Investments ShortTermInvestments	23003000
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1170808000
CY2010Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	25918000
CY2010Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	492000000
CY2010Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	74892000
CY2010Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	9995000
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2010Q4	us-gaap	Liabilities Liabilities	5694238000
CY2010Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	38860748	shares
CY2010Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	40330000
CY2010Q4	us-gaap	Other Assets Current OtherAssetsCurrent	43994000
CY2010Q4	us-gaap	Investments Investments	31851000
CY2010Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1106935000
CY2010Q4	us-gaap	Long Term Debt LongTermDebt	4308742000
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	181033000
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2037134000
CY2010Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	8074000
CY2010Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	162635000
CY2010Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	325477000
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8138000
CY2010Q4	dva	Alliance And Product Supply Agreement Net AllianceAndProductSupplyAgreementNet	25317000
CY2010Q4	dva	Long Term Debt And Other Noncurrent LongTermDebtAndOtherNoncurrent	4769893000
CY2010Q4	dva	Certificates Of Deposit Money Market Funds And Us Government Securities CertificatesOfDepositMoneyMarketFundsAndUSGovernmentSecurities	21803000
CY2010Q4	dva	Acquisition Obligations And Other Notes Payable AcquisitionObligationsAndOtherNotesPayable	9049000
CY2010Q4	dva	Deferred Tax Assets Receivables DeferredTaxAssetsReceivables	110332000
CY2010Q4	dva	Alliance And Product Supply Agreement Gross AllianceAndProductSupplyAgreementGross	68200000
CY2010Q4	dva	Deferred Tax Assets Alliance And Product Supply Agreement DeferredTaxAssetsAllianceAndProductSupplyAgreement	9849000
CY2010Q4	dva	Amortized Intangible Liabilities Accumulated Amortization AmortizedIntangibleLiabilitiesAccumulatedAmortization	42883000
CY2010Q4	dva	Business Acquisition Number Of Entities Acquired BusinessAcquisitionNumberOfEntitiesAcquired	41	Entity
CY2010Q4	dva	Percentage Of Accounts Receivable6 Months Or More Past Due PercentageOfAccountsReceivable6MonthsOrMorePastDue	0.15	pure
CY2010Q4	dva	Interest Rate Margin InterestRateMargin	0.0150	pure
CY2010Q4	dva	Investments And Other Current Assets InvestmentsAndOtherCurrentAssets	713761000
CY2010Q4	dva	Mutual Funds And Common Stock At Fair Value MutualFundsAndCommonStockAtFairValue	10048000
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34231000
CY2011Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Liabilities Incurred BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurred	19010000
CY2011Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	7224000
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	211544000
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15642000
CY2011Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	91305000
CY2011Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	144124000
CY2011Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	29163000
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Gain Loss AvailableForSaleSecuritiesGrossUnrealizedGainLoss	-255000
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	109791000
CY2011Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7842000
CY2011Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4512811000
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	280382000
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19484000
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1631694000
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1153116000
CY2011Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	34173000
CY2011Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3036000
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	222347000
CY2011Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	69962000
CY2011Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	71446000
CY2011Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-142716000
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4417624000
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3195818000
CY2011Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	176910000
CY2011Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	676293000
CY2011Q4	us-gaap	Interest Payable Current InterestPayableCurrent	17469000
CY2011Q4	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	193966000
CY2011Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	7000000
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	4510000
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1195163000
CY2011Q4	us-gaap	Assets Assets	8892172000
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	193874000
CY2011Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	37412000
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	135000
CY2011Q4	us-gaap	Inventory Net InventoryNet	75731000
CY2011Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	350000000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	393752000
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1707994000
CY2011Q4	us-gaap	Other Receivables OtherReceivables	269832000
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	596300000
CY2011Q4	us-gaap	Minority Interest MinorityInterest	127050000
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	4620000
CY2011Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Cash Paid BusinessAcquisitionCostOfAcquiredEntityCashPaid	1077442000
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	42335000
CY2011Q4	us-gaap	Finite Lived Noncompete Agreements Gross FiniteLivedNoncompeteAgreementsGross	335012000
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	325734000
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments CapitalLeasesFutureMinimumPaymentsNetMinimumPayments	43364000
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93641363	shares
CY2011Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1269343000
CY2011Q4	us-gaap	Senior Notes SeniorNotes	1550000000
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Assets Current AssetsCurrent	2281608000
CY2011Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1858567000
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	163770000
CY2011Q4	us-gaap	Goodwill Goodwill	4946976000
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	249613000
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3420000
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	132006000
CY2011Q4	us-gaap	Land Land	23004000
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	479569000
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	4656000
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	118745000
CY2011Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	8943000
CY2011Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	66011000
CY2011Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	87345000
CY2011Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	5000000
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	250343000
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Goodwill DisposalGroupIncludingDiscontinuedOperationGoodwill	7999000
CY2011Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	423098000
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	64620000
CY2011Q4	us-gaap	Long Term Investments LongTermInvestments	9890000
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2737143000
CY2011Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	463927000
CY2011Q4	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.0527	pure
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	232569000
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1304492000
CY2011Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	164404000
CY2011Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Purchase Price BusinessAcquisitionCostOfAcquiredEntityPurchasePrice	1096452000
CY2011Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	64120000
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8892172000
CY2011Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	8081000
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2011Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	41514000
CY2011Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	439203000
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	176063000
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	2141075000
CY2011Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	71384000
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	134862283	shares
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	21256000
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Net DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet	5183000
CY2011Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	409104000
CY2011Q4	us-gaap	Temporary Equity Carrying Amount TemporaryEquityCarryingAmount	478216000
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	17399000
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	635608000
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1432651000
CY2011Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	27325000
CY2011Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	606643000
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	87345000
CY2011Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	15174000
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	4239000
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2011Q4	us-gaap	Liabilities Liabilities	6145831000
CY2011Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	258336000
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	41220920	shares
CY2011Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	4260000
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	49349000
CY2011Q4	us-gaap	Investments Investments	27289000
CY2011Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1266499000
CY2011Q4	us-gaap	Long Term Debt LongTermDebt	4504969000
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	289653000
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2268125000
CY2011Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	43364000
CY2011Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5500000	shares
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	159491000
CY2011Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	125106000
CY2011Q4	dva	Accounts Receivable Months Outstanding AccountsReceivableMonthsOutstanding	P4M
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	412972000
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8943000
CY2011Q4	dva	Major Facility Lease Terms Minimum Period In Years MajorFacilityLeaseTermsMinimumPeriodInYears	5	Year
CY2011Q4	dva	Major Facility Lease Terms Maximum Period In Years MajorFacilityLeaseTermsMaximumPeriodInYears	15	Year
CY2011Q4	dva	Renewal Option Terms Minimum Additional Period In Years RenewalOptionTermsMinimumAdditionalPeriodInYears	5	Year
CY2011Q4	dva	Renewal Option Terms Maximum Additional Period In Years RenewalOptionTermsMaximumAdditionalPeriodInYears	10	Year
CY2011Q4	dva	Alliance And Product Supply Agreement Net AllianceAndProductSupplyAgreementNet	19987000
CY2011Q4	dva	Long Term Debt And Other Noncurrent LongTermDebtAndOtherNoncurrent	4992715000
CY2011Q4	dva	Other Commitments OtherCommitments	4000000
CY2011Q4	dva	Certificates Of Deposit Money Market Funds And Us Government Securities CertificatesOfDepositMoneyMarketFundsAndUSGovernmentSecurities	11754000
CY2011Q4	dva	Acquisition Obligations And Other Notes Payable AcquisitionObligationsAndOtherNotesPayable	37447000
CY2011Q4	dva	Deferred Tax Assets Receivables DeferredTaxAssetsReceivables	125159000
CY2011Q4	dva	Long Term Debt Maturities Repayments Of Principal In Year Six And Thereafter LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSixAndThereafter	1588590000
CY2011Q4	dva	Alliance And Product Supply Agreement Gross AllianceAndProductSupplyAgreementGross	68200000
CY2011Q4	dva	Deferred Tax Assets Alliance And Product Supply Agreement DeferredTaxAssetsAllianceAndProductSupplyAgreement	7775000
CY2011Q4	dva	Amortized Intangible Liabilities Accumulated Amortization AmortizedIntangibleLiabilitiesAccumulatedAmortization	48213000
CY2011Q4	dva	Share Based Compensation Shares Authorized Under Stock Option Plans Stock Appreciation And Stock Units Exercise Price Range Number Of Awards Exercisable ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansStockAppreciationAndStockUnitsExercisePriceRangeNumberOfAwardsExercisable	4352249	shares
CY2011Q4	dva	Share Based Compensation Shares Authorized Under Stock Option Plans Stock Appreciation And Stock Units Exercise Price Range Number Of Awards Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansStockAppreciationAndStockUnitsExercisePriceRangeNumberOfAwardsOutstanding	10718672	shares
CY2011Q4	dva	Debt Instrument Redemption Date DebtInstrumentRedemptionDate	2010-11-19
CY2011Q4	dva	Business Acquisition Number Of Entities Acquired BusinessAcquisitionNumberOfEntitiesAcquired	178	Entity
CY2011Q4	dva	Number Of Entities That Third Parties Held Non Controlling Ownership NumberOfEntitiesThatThirdPartiesHeldNonControllingOwnership	196	Entity
CY2011Q4	dva	Exercise Price Of Warrants ExercisePriceOfWarrants	14.22
CY2011Q4	dva	Percentage Of Accounts Receivable6 Months Or More Past Due PercentageOfAccountsReceivable6MonthsOrMorePastDue	0.16	pure
CY2011Q4	dva	Disposal Group Including Discontinued Operation Net Assets DisposalGroupIncludingDiscontinuedOperationNetAssets	83730000
CY2011Q4	dva	Investments And Other Current Assets InvestmentsAndOtherCurrentAssets	692693000
CY2011Q4	dva	Disposal Group Including Discontinued Operation Liabilities And Minority Interest DisposalGroupIncludingDiscontinuedOperationLiabilitiesAndMinorityInterest	836000
CY2011Q4	dva	Held To Maturity Securities Released From Regulatory Agencies HeldToMaturitySecuritiesReleasedFromRegulatoryAgencies	11313000
CY2011Q4	dva	Mutual Funds And Common Stock At Fair Value MutualFundsAndCommonStockAtFairValue	15535000
CY2011Q4	dva	Percentage Of Outstanding Patient Accounts Receivables PercentageOfOutstandingPatientAccountsReceivables	1.00	pure
CY2010Q4	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	264742000
CY2010Q4	dva	Premium On Debt Redemption PremiumOnDebtRedemption	6677000
CY2010Q4	dva	Debt Expense And Redemption Charges DebtExpenseAndRedemptionCharges	74431000
CY2010Q4	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	The New Senior Notes will pay interest on May 1 and November 1 of each year, beginning May 1, 2011
CY2010Q4	us-gaap	Debt Instrument Covenant Description DebtInstrumentCovenantDescription	The borrowings under the Credit Agreement are guaranteed by substantially all of the Company’s direct and indirect wholly-owned domestic subsidiaries and are secured by substantially all of the Company’s and its guarantors’ assets. The Credit Agreement contains customary affirmative and negative covenants such as various restrictions on investments, acquisitions, the payment of dividends, redemptions and acquisitions of capital stock, capital expenditures and other indebtedness, as well as limitations on the amount of tangible net assets in non-guarantor subsidiaries. However, many of these restrictions will not apply as long as the Company’s leverage ratio is below 3.50:1.00. In addition, the Credit Agreement requires compliance with financial covenants including an interest coverage ratio and a leverage ratio that determines the interest rate margins as described above.
CY2010Q3	us-gaap	Payments To Acquire Land PaymentsToAcquireLand	12000000
CY2010Q3	dva	Estimated Construction Cost EstimatedConstructionCost	95000000
CY2011Q4	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	3555000
CY2011Q3	dva	Number Of Centers To Be Divest NumberOfCentersToBeDivest	30	Entity
CY2009	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	645000
CY2009	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-11362000
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeBeforeTax	17253000
CY2009	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	57075000
CY2009	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	153495000
CY2009	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	67908000
CY2009	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-130798000
CY2009	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	44376000
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-346060000
CY2009	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	342702000
CY2009	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	46896000
CY2009	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	57075000
CY2009	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-4250000
CY2009	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32313000
CY2009	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	9375000
CY2009	us-gaap	Income Taxes Paid IncomeTaxesPaid	161671000
CY2009	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	422291000
CY2009	us-gaap	Costs And Expenses CostsAndExpenses	5004625000
CY2009	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease	7964000
CY2009	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	666710000
CY2009	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	63653000
CY2009	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	431475000
CY2009	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	393000
CY2009	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	757579000
CY2009	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	18241000
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	44422000
CY2009	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	479366000
CY2009	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.06
CY2009	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1614000
CY2009	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2062000
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax	6711000
CY2009	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	8791000
CY2009	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	6859000
CY2009	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	34415000
CY2009	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	50869000
CY2009	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-2578000
CY2009	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	67748000
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	-159000
CY2009	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.008	pure
CY2009	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4993000
CY2009	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	18828824000
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	422417000
CY2009	us-gaap	Net Income Loss NetIncomeLoss	422684000
CY2009	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecrease	13033000
CY2009	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	16693000
CY2009	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	564000	shares
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	422417000
CY2009	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.05
CY2009	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	6950000
CY2009	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease	-5069000
CY2009	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	5944253000
CY2009	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.030	pure
CY2009	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease	827000
CY2009	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Before Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentBeforeTaxPeriodIncreaseDecrease	1353000
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	274605000
CY2009	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.08
CY2009	us-gaap	Depreciation And Amortization DepreciationAndAmortization	228396000
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	-102000
CY2009	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	5757946000
CY2009	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-104879000
CY2009	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-43543000
CY2009	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	393000
CY2009	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	252000
CY2009	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	8152000
CY2009	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	193181000
CY2009	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	22664000
CY2009	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	6950000
CY2009	us-gaap	Other Comprehensive Income Loss Before Tax Period Increase Decrease OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease	14386000
CY2009	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	44578000
CY2009	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-4220000
CY2009	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	248154000
CY2009	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	44422000
CY2009	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9912000	shares
CY2009	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	14739000
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	-261000
CY2009	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.07
CY2009	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6493000
CY2009	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	213657000
CY2009	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	186951000
CY2009	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	565000
CY2009	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	252000
CY2009	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.002	pure
CY2009	us-gaap	Tax Benefit From Stock Options Exercised TaxBenefitFromStockOptionsExercised	18241000
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	939628000
CY2009	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	488550000
CY2009	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	16810000
CY2009	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-267000
CY2009	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3706000
CY2009	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-628000
CY2009	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	278213000
CY2009	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	128578000
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103603885	shares
CY2009	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	16380000
CY2009	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3627000
CY2009	us-gaap	Interest Paid InterestPaid	186280000
CY2009	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	1642000
CY2009	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	10542000
CY2009	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15115000
CY2009	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2442000
CY2009	us-gaap	Interest Expense Debt InterestExpenseDebt	176100000
CY2009	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	986000
CY2009	us-gaap	Other Comprehensive Income Available For Sale Securities Tax OtherComprehensiveIncomeAvailableForSaleSecuritiesTax	-526000
CY2009	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.367	pure
CY2009	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	7697000
CY2009	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	87617000
CY2009	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-9138000
CY2009	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	531531000
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104167685	shares
CY2009	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-5595000
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-192072000
CY2009	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	9655000
CY2009	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	393000
CY2009	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037	pure
CY2009	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	18767592000
CY2009	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7288000
CY2009	us-gaap	Profit Loss ProfitLoss	479759000
CY2009	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2009	dva	Assets Acquired In Noncash Asset Exchange AssetsAcquiredInNoncashAssetExchange	2618000
CY2009	dva	Increase Decrease In Other Current Receivables And Other Current Assets IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets	35104000
CY2009	dva	Proceeds From Repayments Of Long Term Debt ProceedsFromRepaymentsOfLongTermDebt	-61274000
CY2009	dva	Patient Care Costs PatientCareCosts	4242147000
CY2009	dva	Debt Expense DebtExpense	185755000
CY2009	dva	Adjustment Income Loss From Equity Method Investments AdjustmentIncomeLossFromEquityMethodInvestments	204000
CY2009	dva	Adjustment Depreciation And Amortization AdjustmentDepreciationAndAmortization	228986000
CY2009	dva	Distributions From Equity Investments DistributionsFromEquityInvestments	2547000
CY2009	dva	Income Tax Expense Benefit Continuing Operations And Discontinued Operations IncomeTaxExpenseBenefitContinuingOperationsAndDiscontinuedOperations	278465000
CY2009	dva	Proceeds From Sale Of Investments In Securities And Other ProceedsFromSaleOfInvestmentsInSecuritiesAndOther	8465000
CY2009	dva	Changes From Net Income Attributable To Parent And Transfers From To Noncontrolling Interests ChangesFromNetIncomeAttributableToParentAndTransfersFromToNoncontrollingInterests	418434000
CY2009	dva	Gain Loss On Disposal Of Assets And Other Noncash Charges GainLossOnDisposalOfAssetsAndOtherNoncashCharges	20945000
CY2009	dva	Cash Contribution From Noncontrolling Interest CashContributionFromNoncontrollingInterest	13071000
CY2009	dva	Repayment Of Debt RepaymentOfDebt	42000
CY2009	dva	Payments To Acquire Equity Method Investments And Other Assets PaymentsToAcquireEquityMethodInvestmentsAndOtherAssets	2429000
CY2009	dva	Debt Expense And Redemption Charges DebtExpenseAndRedemptionCharges	185755000
CY2009	dva	Assets Received For Additional Noncontrolling Interests AssetsReceivedForAdditionalNoncontrollingInterests	51000
CY2009	dva	Weighted Average Number Basic Shares Outstanding Adjustment WeightedAverageNumberBasicSharesOutstandingAdjustment	103595000	shares
CY2009	dva	Stock Issued Or Vested During Period Shares Stock Awards StockIssuedOrVestedDuringPeriodSharesStockAwards	9000	shares
CY2009	dva	Income Loss From Continuing Operations Available To Common Stockholders Basic IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic	422024000
CY2009	dva	Income Loss From Continuing Operations Available To Common Stockholders Diluted IncomeLossFromContinuingOperationsAvailableToCommonStockholdersDiluted	422024000
CY2009	dva	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	5601551000
CY2009	dva	Health Care Organization Revenue Before Provision For Uncollectible Accounts HealthCareOrganizationRevenueBeforeProvisionForUncollectibleAccounts	6100648000
CY2009	dva	Provision For Doubtful Accounts Provided During Period ProvisionForDoubtfulAccountsProvidedDuringPeriod	156395000
CY2009	dva	Provision For Doubtful Accounts Previously Reported ProvisionForDoubtfulAccountsPreviouslyReported	161388000
CY2009	dva	Provision For Doubtful Accounts Related To Patient Service Revenue ProvisionForDoubtfulAccountsRelatedToPatientServiceRevenue	156395000
CY2010	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	468000
CY2010	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	618496000
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	53760000
CY2010	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-643338000
CY2010	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4740000
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeBeforeTax	9093000
CY2010	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	78536000
CY2010	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	67901000
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-436633000
CY2010	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	394507000
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	67935000
CY2010	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	78536000
CY2010	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-5835000
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-55379000
CY2010	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3410000
CY2010	us-gaap	Income Taxes Paid IncomeTaxesPaid	207265000
CY2010	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	No other single payor accounted for more than 5% of total accounts receivable.
CY2010	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	405402000
CY2010	us-gaap	Costs And Expenses CostsAndExpenses	5275189000
CY2010	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease	5423000
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	839683000
CY2010	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	48686000
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	411734000
CY2010	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	471354000
CY2010	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	281000
CY2010	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	69000
CY2010	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease	-3453000
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	218666000
CY2010	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecrease	8876000
CY2010	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	900000
CY2010	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1555000	shares
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	405615000
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	743990000
CY2010	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	26706000
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	45551000
CY2010	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	6983641000
CY2010	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	4.58
CY2010	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	483938000
CY2010	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.94
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1007000
CY2010	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	1125000
CY2010	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	8918760	shares
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax	3536000
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	6051000
CY2010	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	14214000
CY2010	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	5000000
CY2010	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	31338000
CY2010	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	75399000
CY2010	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-134000
CY2010	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	69.35
CY2010	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	83591000
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	13000
CY2010	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1515000
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002	pure
CY2010	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4351000
CY2010	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24134502000
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	405615000
CY2010	us-gaap	Net Income Loss NetIncomeLoss	405683000
CY2010	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	187000
CY2010	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	9341000
CY2010	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	153502000
CY2010	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	56615000
CY2010	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	6283000
CY2010	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	618496000
CY2010	us-gaap	Other Comprehensive Income Loss Before Tax Period Increase Decrease OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease	9905000
CY2010	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-45737000
CY2010	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-217000
CY2010	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	266849000
CY2010	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45551000
CY2010	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1452000	shares
CY2010	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	15064000
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	22000
CY2010	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.99
CY2010	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	24139000
CY2010	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	7498000
CY2010	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.350	pure
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4228000
CY2010	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-111444000
CY2010	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	281000
CY2010	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	17273000
CY2010	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-68000
CY2010	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3419000
CY2010	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	22727000
CY2010	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	188502000
CY2010	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	39588000
CY2010	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.93
CY2010	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	152252000
CY2010	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	6283000
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-392000
CY2010	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	4.65
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	260052000
CY2010	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	320658000
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101504373	shares
CY2010	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	59932000
CY2010	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	6271749000
CY2010	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease	628000
CY2010	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Before Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentBeforeTaxPeriodIncreaseDecrease	1029000
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	273602000
CY2010	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.00
CY2010	us-gaap	Depreciation And Amortization DepreciationAndAmortization	233730000
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	9000
CY2010	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	355464000
CY2010	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	480000
CY2010	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	187000
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001	pure
CY2010	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	471635000
CY2010	us-gaap	Tax Benefit From Stock Options Exercised TaxBenefitFromStockOptionsExercised	26706000
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	996560000
CY2010	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	490270000
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.040	pure
CY2010	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	6043543000
CY2010	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2621000
CY2010	us-gaap	Interest Paid InterestPaid	190949000
CY2010	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	83000
CY2010	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	5557000
CY2010	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3892000
CY2010	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8999000
CY2010	us-gaap	Interest Expense Debt InterestExpenseDebt	172265000
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	615000
CY2010	us-gaap	Other Comprehensive Income Available For Sale Securities Tax OtherComprehensiveIncomeAvailableForSaleSecuritiesTax	-401000
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	579000000
CY2010	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	12128000
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103059171	shares
CY2010	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-3854000
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-82392000
CY2010	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	9342000
CY2010	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	281000
CY2010	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039	pure
CY2010	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	24809258000
CY2010	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-901000
CY2010	us-gaap	Profit Loss ProfitLoss	484219000
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2010	dva	Increase Decrease In Other Current Receivables And Other Current Assets IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets	44719000
CY2010	dva	Proceeds From Repayments Of Long Term Debt ProceedsFromRepaymentsOfLongTermDebt	560946000
CY2010	dva	Supplemental Assets Acquired Under Capital Leases SupplementalAssetsAcquiredUnderCapitalLeases	3983000
CY2010	dva	Patient Care Costs PatientCareCosts	4467107000
CY2010	dva	Debt Expense DebtExpense	181607000
CY2010	dva	Adjustment Income Loss From Equity Method Investments AdjustmentIncomeLossFromEquityMethodInvestments	3298000
CY2010	dva	Adjustment Depreciation And Amortization AdjustmentDepreciationAndAmortization	234378000
CY2010	dva	Distributions From Equity Investments DistributionsFromEquityInvestments	361000
CY2010	dva	Increase Non Controlling Interest IncreaseNonControllingInterest	1139000
CY2010	dva	Income Tax Expense Benefit Continuing Operations And Discontinued Operations IncomeTaxExpenseBenefitContinuingOperationsAndDiscontinuedOperations	260239000
CY2010	dva	Proceeds From Sale Of Investments In Securities And Other ProceedsFromSaleOfInvestmentsInSecuritiesAndOther	2744000
CY2010	dva	Changes From Net Income Attributable To Parent And Transfers From To Noncontrolling Interests ChangesFromNetIncomeAttributableToParentAndTransfersFromToNoncontrollingInterests	399848000
CY2010	dva	Goodwill Other GoodwillOther	-13000
CY2010	dva	Gain Loss On Disposal Of Assets And Other Noncash Charges GainLossOnDisposalOfAssetsAndOtherNoncashCharges	9585000
CY2010	dva	Cash Contribution From Noncontrolling Interest CashContributionFromNoncontrollingInterest	9510000
CY2010	dva	Repayment Of Debt RepaymentOfDebt	113810000
CY2010	dva	Payments To Acquire Equity Method Investments And Other Assets PaymentsToAcquireEquityMethodInvestmentsAndOtherAssets	709000
CY2010	dva	Debt Expense And Redemption Charges DebtExpenseAndRedemptionCharges	255989000
CY2010	dva	Debt Refinancing And Redemption Charges DebtRefinancingAndRedemptionCharges	74382000
CY2010	dva	Weighted Average Number Basic Shares Outstanding Adjustment WeightedAverageNumberBasicSharesOutstandingAdjustment	101497000	shares
CY2010	dva	Stock Issued Or Vested During Period Shares Stock Awards StockIssuedOrVestedDuringPeriodSharesStockAwards	7000	shares
CY2010	dva	Income Loss From Continuing Operations Available To Common Stockholders Basic IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic	405334000
CY2010	dva	Income Loss From Continuing Operations Available To Common Stockholders Diluted IncomeLossFromContinuingOperationsAvailableToCommonStockholdersDiluted	405334000
CY2010	dva	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	5877242000
CY2010	dva	Health Care Organization Revenue Before Provision For Uncollectible Accounts HealthCareOrganizationRevenueBeforeProvisionForUncollectibleAccounts	6438050000
CY2010	dva	Provision For Doubtful Accounts Provided During Period ProvisionForDoubtfulAccountsProvidedDuringPeriod	166301000
CY2010	dva	Provision For Doubtful Accounts Previously Reported ProvisionForDoubtfulAccountsPreviouslyReported	170652000
CY2010	dva	Provision For Doubtful Accounts Related To Patient Service Revenue ProvisionForDoubtfulAccountsRelatedToPatientServiceRevenue	166301000
CY2011	dei	Trading Symbol TradingSymbol	DVA
CY2011	dei	Entity Registrant Name EntityRegistrantName	DAVITA INC
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Document Type DocumentType	8-K
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0000927066
CY2011	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1896000
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	323348000
CY2011	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1795363000
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11316000
CY2011	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-374843000
CY2011	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	11061000
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeBeforeTax	15911000
CY2011	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>16. Contingencies</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The majority of the Company’s revenues are from government programs and may be subject to adjustment as a result of: (1) examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (2) differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (3) differing opinions regarding a patient’s medical diagnosis or the medical necessity of services provided; and (4) retroactive applications or interpretations of governmental requirements. In addition, the Company’s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>    Inquiries by the Federal Government and Certain Related Civil Proceedings</i></b></font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><u>2005 U.S. Attorney Investigation:</u> In March 2005, the Company received a subpoena from the U.S. Attorney’s Office for the Eastern District of Missouri in St. Louis. The subpoena required production of a wide range of documents relating to the Company’s operations, including documents related to, among other things, pharmaceutical and other services provided to patients, relationships with pharmaceutical companies, and financial relationships with physicians and joint ventures. The subpoena covers the period from December 1, 1996 through March 2005. In October 2005, the Company received a follow-up request for additional documents related to specific medical director and joint venture arrangements. In February 2006, the Company received an additional subpoena for documents, including certain patient records relating to the administration and billing of EPO. In May 2007, the Company received a request for documents related to durable medical equipment and supply companies owned and operated by the Company. The Company cooperated with the inquiry and has produced the requested records. The subpoenas were issued in connection with a joint civil and criminal investigation. It is possible that criminal proceedings may be initiated against the Company in connection with this investigation. The Company has not received a communication from the St. Louis U.S. Attorney’s Office on this matter in over two years.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><u>Woodard Private Civil Suit:</u> In February 2007, the Company received a request for information from the Office of Inspector General, U.S. Department of Health and Human Services, or OIG, for records relating to EPO claims submitted to Medicare. In August 2007, the Company received a subpoena from the OIG seeking similar documents. The requested documents relate to services provided from 2001 to 2004 by a number of the Company’s centers. The request and subpoena were sent from the OIG’s offices in Houston and Dallas, Texas. The Company cooperated with the inquiry and has produced all previously requested records to date. The Company was contacted by the U.S. Attorney’s Office for the Eastern District of Texas, which stated that this was a civil investigation related to EPO claims. On July 6, 2009, the United States District Court for the Eastern District of Texas lifted the seal on the civil <i>qui tam</i> complaint related to these previous requests for information. The Company was subsequently served with a complaint by the relator, Ivey Woodard, purportedly on behalf of the federal government, under the <i>qui tam</i> provisions of the federal False Claims Act. The government did not intervene and is not actively pursuing this matter. The relator is pursuing the claims independently and the parties are engaged in active litigation. The complaint contains allegations relating to the Company’s EPO practices for the period from 1992 through 2010 and seeks monetary damages and civil penalties as well as costs and expenses. The court has ruled that claims earlier than 1996 are beyond the statute of limitations. The Company believes that there is some overlap between the subject of this complaint and the review of EPO utilization in the 2005 U.S. Attorney investigation described above. The Company is vigorously defending this matter and intends to continue to do so. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><u>Vainer Private Civil Suit:</u> In December 2008, the Company received a subpoena for documents from the OIG relating to the pharmaceutical products Zemplar, Hectorol, Venofer, Ferrlecit and EPO, as well as other related matters. The subpoena covers the period from January 2003 to December 2008. The Company was in contact with the U.S. Attorney’s Office for the Northern District of Georgia and the U.S. Department of Justice in Washington, DC, since November 2008 relating to this matter, and was advised that this was a civil inquiry. On June 17, 2009, the Company learned that the allegations underlying this inquiry were made as part of a civil complaint filed by individuals and brought pursuant to the <i>qui tam</i> provisions of the federal False Claims Act. On April 1, 2011, the United States District Court for the Northern District of Georgia ordered the case to be unsealed. At that time, the Department of Justice and U.S. Attorney’s Office filed a notice of declination stating that the United States would not be intervening and not pursuing the relators’ allegation in litigation. On July 25, 2011, the relators, Daniel Barbir and Dr. Alon Vainer, filed their amended complaint in the United States District Court for the Northern District of Georgia, purportedly on behalf of the federal government. The allegations in the complaint relate to the Company’s drug administration practices for Vitamin D and iron agents for a period from 2003 through 2010. The complaint seeks monetary damages and civil penalties as well as costs and expenses. The Company is vigorously defending this matter and intends to continue to do so. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><u>2010 U.S. Attorney Physician Relationship Investigation:</u> In May 2010, the Company received a subpoena from the OIG’s office in Dallas, Texas. The subpoena covers the period from January 1, 2005 to May 2010, and seeks production of a wide range of documents relating to the Company’s operations, including documents related to, among other things, financial relationships with physicians and joint ventures. The general subject matter of the inquiry appears to overlap with the 2005 U.S. Attorney Investigation described above. The Company met with representatives of the government to discuss the scope of the subpoena and the production of responsive documents. The Company has been advised that this is a civil investigation. The Company is cooperating with the inquiry and is producing the requested records. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><u>2011 U.S. Attorney Physician Relationship Investigation:</u> In August 2011, the Company announced it had learned that the U.S. Attorney’s Office for the District of Colorado would be looking into certain activities of the Company in connection with information being provided to a grand jury. The Company announced further that it understood that this investigation was at a very preliminary stage, and while its precise scope was unclear, it appeared to overlap, at least in part, with the 2005 U.S. Attorney Investigation and 2010 U.S. Attorney Physician Relationship Investigation described above. Subsequent to the Company’s announcement of this 2011 U.S. Attorney Physician Relationship Investigation, it received a subpoena for documents which substantially overlaps with the subpoena in the 2010 U.S. Attorney Physician Relationship Investigation described above and covers the period from January 2006 to September 2011. The Company is cooperating with the government and is producing the requested records. Certain current and former members of the Board and executives received subpoenas in November 2011 and thereafter to testify before the grand jury, and other Company representatives may also receive subpoenas for testimony related to this matter. The Company can make no assurances as to the time or resources that will be needed to devote to this litigation or its final outcome.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><u>2011 U.S. Attorney Medicaid Investigation:</u> In October 2011, the Company announced that it would be receiving a request for documents, which could include an administrative subpoena from the Office of Inspector General for the U.S. Department of Health and Human Services. Subsequent to the Company’s announcement of this 2011 U.S. Attorney Medicaid Investigation, the Company received a request for documents in connection with the inquiry by the United States Attorney’s Office for the Eastern District of New York. The request relates to payments for infusion drugs covered by Medicaid composite payments for dialysis. The Company believes this inquiry is civil in nature. The Company does not know the time period or scope. The Company understands that certain other providers that operate dialysis clinics in New York may be receiving or have received a similar request for documents. The Company intends to cooperate with the government to provide responsive documents.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Except for the private civil complaints filed by the relators as described above, to the Company’s knowledge, no proceedings have been initiated against the Company at this time in connection with any of the inquiries by the federal government. Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved, it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and on-going discussions with regulators. Responding to the subpoenas or inquiries and defending the Company in the relator proceedings will continue to require management’s attention and significant legal expense. Any negative findings in the inquiries or relator proceedings could result in substantial financial penalties or awards against the Company, exclusion from future participation in the Medicare and Medicaid programs and, to the extent criminal proceedings may be initiated against the Company, possible criminal penalties. At this time, the Company cannot predict the ultimate outcome of these inquiries, or the potential outcome of the relators claims, or the potential range of damages, if any.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>    Other</i></b></font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The Company has received several notices of claims from commercial payors and other third parties related to historical billing practices and claims against DVA Renal Healthcare (formerly known as Gambro Healthcare), a subsidiary of the Company, related to historical Gambro Healthcare billing practices and other matters covered by its 2004 settlement agreement with the Department of Justice and certain agencies of the U.S. government. The Company has received no further indication that any of these claims are active, and some of them may be barred by applicable statutes of limitations. To the extent any of these claims might proceed, the Company intends to defend against them vigorously; however, the Company may not be successful and these claims may lead to litigation and any such litigation may be resolved unfavorably. At this time, the Company cannot predict the ultimate outcome of this matter or the potential range of damages, if any.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">A wage and hour claim, which has been styled as a class action, is pending against the Company in the Superior Court of California. The Company was served with the complaint in this lawsuit in April 2008, and it has been amended since that time. The lawsuit, as amended, alleges that the Company failed to provide meal periods, failed to pay compensation in lieu of providing rest or meal periods, failed to pay overtime, and failed to comply with certain other California Labor Code requirements. In September 2011, the court denied the plaintiffs’ motion for class certification. Plaintiffs have appealed that decision. The Company intends to continue to vigorously defend against these claims. Any potential settlement of these claims is not anticipated to be material to the Company’s consolidated financial statements.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In October 2007, the Company was contacted by the Attorney General’s Office for the State of Nevada. The Attorney General’s Office informed the Company that it was conducting a civil and criminal investigation of the Company’s operations in Nevada and that the investigation related to the billing of pharmaceuticals, including EPO. In February 2008, the Attorney General’s Office informed the Company that the civil and criminal investigation had been discontinued. The Attorney General’s Office further advised the Company that Nevada Medicaid intended to conduct audits of end stage renal disease (ESRD) dialysis providers in Nevada and such audits would relate to the issues that were the subjects of the investigation. To the Company’s knowledge, no court proceedings have been initiated against the Company at this time. Any negative audit findings could result in a substantial repayment by the Company. At this time, the Company cannot predict the ultimate outcome of this matter or the potential range of damages, if any.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In June 2004, DVA Renal Healthcare was served with a complaint filed in the Superior Court of California by one of its former employees who worked for its California acute services program. The complaint, which is styled as a class action, alleges, among other things, that DVA Renal Healthcare failed to provide overtime wages, defined rest periods and meal periods, or compensation in lieu of such provisions and failed to comply with certain other California Labor Code requirements. The parties have reached an agreement, subject to approval by the court, which fully resolves this matter for an amount that did not materially impact the Company’s financial results.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In addition to the foregoing, the Company is subject to claims and suits, including from time to time, contractual disputes and professional and general liability claims, as well as audits and investigations by various government entities, in the ordinary course of business. The Company believes that the ultimate resolution of any such pending proceedings, whether the underlying claims are covered by insurance or not, will not have a material adverse effect on its financial condition, results of operations or cash flows.</font></p> </div>
CY2011	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	95394000
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	46779000
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1399228000
CY2011	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	519404000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	98235000
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	458014000
CY2011	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax	-4756000
CY2011	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	95394000
CY2011	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	-10785000
CY2011	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000000
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	88848000
CY2011	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	9687000
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	145687000
CY2011	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	No other single payor accounted for more than 5% of total accounts receivable.
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	481755000
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	5661198000
CY2011	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease	-19328000
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1180046000
CY2011	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	5443000
CY2011	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	524379000
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-3754000
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	786000
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	892674000
CY2011	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	38199000
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	48718000
CY2011	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	7309901000
CY2011	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	5.39
CY2011	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	576930000
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.96
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	53438000
CY2011	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-29049000
CY2011	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4300000000
CY2011	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	1297215000
CY2011	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	85.21
CY2011	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	100653000
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	-57000
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-986000
CY2011	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	5971000
CY2011	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3794686	shares
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax	6190000
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	-19987000
CY2011	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	13689000
CY2011	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	44000000
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	44403000
CY2011	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-693000
CY2011	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	323348000
CY2011	us-gaap	Other Comprehensive Income Loss Before Tax Period Increase Decrease OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease	-32712000
CY2011	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	77418000
CY2011	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-47544000
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2052000
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.008	pure
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7331000
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	36249584000
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	478336000
CY2011	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition	1.4	Year
CY2011	us-gaap	Net Income Loss NetIncomeLoss	478001000
CY2011	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	675000
CY2011	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	16648000
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	217885000
CY2011	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	37628000
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	20834000
CY2011	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	24000000
CY2011	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	358200000
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	296051000
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48718000
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2388000	shares
CY2011	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	17568000
CY2011	us-gaap	Significant Supply Commitment Description SignificantSupplyCommitmentDescription	Certain consolidated joint ventures are contractually scheduled to dissolve after terms ranging from ten to fifty years.
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	-93000
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.09
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2033000
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6659000
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	249060000
CY2011	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPeriodIncreaseDecrease	-31633000
CY2011	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1149000
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.003	pure
CY2011	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1874000	shares
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	478336000
CY2011	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.99
CY2011	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	889506000
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	20834000
CY2011	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease	12305000
CY2011	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	6791980000
CY2011	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-4756000
CY2011	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease	-659000
CY2011	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Before Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentBeforeTaxPeriodIncreaseDecrease	-1079000
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	400156000
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.05
CY2011	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0528	pure
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	266628000
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	-36000
CY2011	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	606651000
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	361000
CY2011	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	675000
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4644000
CY2011	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	520625000
CY2011	us-gaap	Tax Benefit From Stock Options Exercised TaxBenefitFromStockOptionsExercised	38199000
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	1130782000
CY2011	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	553408000
CY2011	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Use of estimates</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with United States generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and temporary equity. Although actual results in subsequent periods will differ from these estimates, such estimates are developed based on the best information available to management and management’s best judgments at the time made. All significant assumptions and estimates underlying the amounts reported in the financial statements and accompanying notes are regularly reviewed and updated when necessary. Changes in estimates are reflected in the financial statements based upon on-going actual experience trends, or subsequent settlements and realizations depending on the nature and predictability of the estimates and contingencies. Interim changes in estimates related to annual operating costs are applied prospectively within annual periods.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The most significant assumptions and estimates underlying these financial statements and accompanying notes involve revenue recognition and accounts receivable, impairments of long-lived assets and valuation adjustments, accounting for income taxes, quarterly and annual variable compensation accruals, purchase accounting valuation estimates, fair value estimates and stock-based compensation. Specific estimating risks and contingencies are further addressed within these notes to the consolidated financial statements.</font></p> </div>
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.042	pure
CY2011	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	6462810000
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	84400000
CY2011	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-51979000
CY2011	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	1221000
CY2011	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	18424000
CY2011	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	335000
CY2011	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2982000
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	384000
CY2011	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	5.50
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	315744000
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-466365000
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94658027	shares
CY2011	us-gaap	Targeted Or Tracking Stock Corporate Events TargetedOrTrackingStockCorporateEvents	The Company’s charter documents include provisions that may deter hostile takeovers, delay or prevent changes of control or changes in management, or limit the ability of stockholders to approve transactions that they may otherwise determine to be in their best interests. These include provisions prohibiting stockholders from acting by written consent, requiring 90 days advance notice of stockholder proposals or nominations to the Board of Directors and granting the Board of Directors the authority to issue up to five million shares of preferred stock and to determine the rights and preferences of the preferred stock without the need for further stockholder approval. The Company is also subject to Section 203 of the Delaware General Corporation Law that, subject to exceptions, would prohibit the Company from engaging in any business combinations with any interested stockholder, as defined in that section, for a period of three years following the date on which that stockholder became an interested stockholder. These restrictions may discourage, delay or prevent a change in the control of the Company.
CY2011	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	47695000
CY2011	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	4887000
CY2011	us-gaap	Interest Paid InterestPaid	236446000
CY2011	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	18495000
CY2011	us-gaap	Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax	9721000
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10270000
CY2011	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8776000
CY2011	us-gaap	Interest Expense Debt InterestExpenseDebt	230953000
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-602000
CY2011	us-gaap	Other Comprehensive Income Available For Sale Securities Tax OtherComprehensiveIncomeAvailableForSaleSecuritiesTax	420000
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.354	pure
CY2011	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	75183000
CY2011	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1077442000
CY2011	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	77074000
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	691243000
CY2011	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	9837000
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96532110	shares
CY2011	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	12725000
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-247183000
CY2011	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	10137000
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3535000
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.041	pure
CY2011	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	36395105000
CY2011	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2039000
CY2011	us-gaap	Profit Loss ProfitLoss	573395000
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2011	dva	Increase Decrease In Other Current Receivables And Other Current Assets IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets	-53697000
CY2011	dva	Proceeds From Repayments Of Long Term Debt ProceedsFromRepaymentsOfLongTermDebt	127660000
CY2011	dva	Supplemental Assets Acquired Under Capital Leases SupplementalAssetsAcquiredUnderCapitalLeases	35764000
CY2011	dva	Proceeds From Issuance Of Senior Notes ProceedsFromIssuanceOfSeniorNotes	1550000000
CY2011	dva	Patient Care Costs PatientCareCosts	4680772000
CY2011	dva	Debt Expense DebtExpense	241090000
CY2011	dva	Adjustment Income Loss From Equity Method Investments AdjustmentIncomeLossFromEquityMethodInvestments	-354000
CY2011	dva	Adjustment Depreciation And Amortization AdjustmentDepreciationAndAmortization	267315000
CY2011	dva	Distributions From Equity Investments DistributionsFromEquityInvestments	340000
CY2011	dva	Proceeds From Sale Of Discontinued Operations ProceedsFromSaleOfDiscontinuedOperations	82000000
CY2011	dva	Income Tax Expense Benefit Continuing Operations And Discontinued Operations IncomeTaxExpenseBenefitContinuingOperationsAndDiscontinuedOperations	315726000
CY2011	dva	Proceeds From Sale Of Investments In Securities And Other ProceedsFromSaleOfInvestmentsInSecuritiesAndOther	3187000
CY2011	dva	Changes From Net Income Attributable To Parent And Transfers From To Noncontrolling Interests ChangesFromNetIncomeAttributableToParentAndTransfersFromToNoncontrollingInterests	467216000
CY2011	dva	Gain Loss On Disposal Of Assets And Other Noncash Charges GainLossOnDisposalOfAssetsAndOtherNoncashCharges	20329000
CY2011	dva	Cash Contribution From Noncontrolling Interest CashContributionFromNoncontrollingInterest	21010000
CY2011	dva	Payments To Acquire Equity Method Investments And Other Assets PaymentsToAcquireEquityMethodInvestmentsAndOtherAssets	2398000
CY2011	dva	Debt Expense And Redemption Charges DebtExpenseAndRedemptionCharges	241090000
CY2011	dva	Cash Tender Premium CashTenderPremium	38933000
CY2011	dva	Proceeds From Notes Payable Additional Amount ProceedsFromNotesPayableAdditionalAmount	823000000
CY2011	dva	Weighted Average Number Basic Shares Outstanding Adjustment WeightedAverageNumberBasicSharesOutstandingAdjustment	94655000	shares
CY2011	dva	Stock Issued Or Vested During Period Shares Stock Awards StockIssuedOrVestedDuringPeriodSharesStockAwards	3000	shares
CY2011	dva	Common Shares Acquired For Cashless Exercise Of Warrants CommonSharesAcquiredForCashlessExerciseOfWarrants	250000	shares
CY2011	dva	Construction Period Description ConstructionPeriodDescription	Construction began in early 2011, and is estimated to be completed in the second half of 2012.
CY2011	dva	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Stock Appreciation And Stock Units Weighted Average Exercise Price ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsStockAppreciationAndStockUnitsWeightedAverageExercisePrice	56.88
CY2011	dva	Share Based Compensation Shares Authorized Under Stock Option Plans Stock Appreciation And Stock Units Exercise Price Range Exercisable Options Weighted Average Exercise Price ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansStockAppreciationAndStockUnitsExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice	50.58
CY2011	dva	Payments Of Interest Rate Cap Premium And Other Deferred Financing Costs PaymentsOfInterestRateCapPremiumAndOtherDeferredFinancingCosts	17861000
CY2011	dva	Increase Decrease In Allowance For Doubtful Accounts IncreaseDecreaseInAllowanceForDoubtfulAccounts	14714000
CY2011	dva	Income Loss From Continuing Operations Available To Common Stockholders Basic IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic	482090000
CY2011	dva	Income Loss From Continuing Operations Available To Common Stockholders Diluted IncomeLossFromContinuingOperationsAvailableToCommonStockholdersDiluted	482090000
CY2011	dva	Health Care Organization Patient Service Revenue Less Provision For Bad Debts HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts	6272576000
CY2011	dva	Health Care Organization Revenue Before Provision For Uncollectible Accounts HealthCareOrganizationRevenueBeforeProvisionForUncollectibleAccounts	6982214000
CY2011	dva	Provision For Doubtful Accounts Provided During Period ProvisionForDoubtfulAccountsProvidedDuringPeriod	190234000
CY2011	dva	Provision For Doubtful Accounts Previously Reported ProvisionForDoubtfulAccountsPreviouslyReported	197565000
CY2011	dva	Provision For Doubtful Accounts Related To Patient Service Revenue ProvisionForDoubtfulAccountsRelatedToPatientServiceRevenue	190234000
CY2010Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	198292000
CY2010Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.04
CY2010Q1	us-gaap	Net Income Loss NetIncomeLoss	109423000
CY2010Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.05
CY2010Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.04
CY2010Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2010Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	242045000
CY2010Q1	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1516271000
CY2010Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	372000
CY2011Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	177580000
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.96
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	94502000
CY2011Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.98
CY2011Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.96
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	235334000
CY2010Q3	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1607008000
CY2011Q1	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1562313000
CY2011Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	131000
CY2010Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	195469000
CY2010Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.04
CY2010Q2	us-gaap	Net Income Loss NetIncomeLoss	107853000
CY2010Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.06
CY2010Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.04
CY2010Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2010Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	242512000
CY2010Q2	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1543855000
CY2010Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-89000
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	187283000
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	100015000
CY2011Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	24000000
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.05
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.02
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	246624000
CY2011Q2	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1661233000
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	253000
CY2010Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	218014000
CY2010Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2010Q3	us-gaap	Net Income Loss NetIncomeLoss	119387000
CY2010Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.16
CY2010Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.15
CY2010Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2010Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	256745000
CY2010Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-95000
CY2011Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	258662000
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.42
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	135361000
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.48
CY2011Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.45
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.45
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	318712000
CY2011Q3	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1757830000
CY2011Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2612000
CY2010Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	132215000
CY2010Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2010Q4	us-gaap	Net Income Loss NetIncomeLoss	69020000
CY2010Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.71
CY2010Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.70
CY2010Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.71
CY2010Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	255258000
CY2010Q4	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1604615000
CY2010Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	93000
CY2011Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	269149000
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	148123000
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.60
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.58
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2011Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	330112000
CY2011Q4	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	1810604000
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1307000

Files In Submission

Name	View Source	Status
0001193125-12-296374-index-headers.html	Edgar Link	pending
0001193125-12-296374-index.html	Edgar Link	pending
0001193125-12-296374.txt	Edgar Link	pending
0001193125-12-296374-xbrl.zip	Edgar Link	pending
d373861d8k.htm	Edgar Link	pending
d373861dex231.htm	Edgar Link	pending
d373861dex991.htm	Edgar Link	pending
dva-20111231.xml	Edgar Link	completed
dva-20111231.xsd	Edgar Link	pending
dva-20111231_cal.xml	Edgar Link	unprocessable
dva-20111231_def.xml	Edgar Link	unprocessable
dva-20111231_lab.xml	Edgar Link	unprocessable
dva-20111231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DVA
DAVITA INC. Stock $dva

2010 Q4 Form 8-K Financial Statement

#000119312512296374 Filed on July 06, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DVA DAVITA INC. Stock $dva

2010 Q4 Form 8-K Financial Statement

#000119312512296374 Filed on July 06, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DVA
DAVITA INC. Stock $dva